20+ Years Inside CRO/CDMO Operations
150+ Technically Vetted Indian Providers
USFDA / EMA / MHRA / TGA Submission-Ready Oversight
Programs Governed Across US · EU · Japan · APAC
ScientificStrategy
PartnerSelection
Regulatory
Quality &Compliance
ProgramGovernance
TechnicalOversight
Vendor self-reporting without objective verification
Regulatory surprises during submission or inspection
Snapshot audits that miss early failure signals
Data integrity gaps discovered too late
AI-assisted vendor scoring across 150+ parameters
Early-warning dashboards for quality, delivery, and compliance risk
Human-led validation by senior CRO/CDMO veterans and auditors
Quarterly re-assessments under annual retainers
Across global drug development and operations
Across therapeutic areas and advanced modalities
Vetted relationships with leading global partners
Global compliance, audit, and submission support
Primary Focus: Pharma, Biopharma & Advanced Modalities
Empowering emerging biotechs, virtual pharma sponsors, venture-backed startups, and global innovators entering India.
One Conflict-Free Governance Layer Across Your Development Program
Your CROs, CDMOs and specialist providers execute the work.
Aventiq Bio connects the science, partners, milestones and technical decisions — helping sponsors identify risks early and maintain on-ground technical visibility across outsourced development programs.
DISCOVERY
Identify & validate novel targets and leads
LEAD OPTIMISATION
Optimize and select clinical candidate
IND/CTA
Prepare and submit regulatory application
CLINICAL DEVELOPMENT
Evaluate safety and efficacy in humans
REGULATORY
Regulatory review and market authorization
COMMERCIAL
Market access and lifecycle management
When does independent technical oversight add value?
Outsourced development brings together scientific, CMC, quality and operational workstreams.
Aventiq Bio helps sponsors assess external partners, review program readiness and address execution risks at key decision points.
Engage Aventiq at these stages of your program.
Qualifying a CRO or CDMO
Assess whether a provider’s capabilities, quality systems, capacity and operating model fit your program before finalizing scope and responsibilities.
Preparing for a Critical Decision
Before technology transfer, scale-up, submission or clinical supply, review whether the available evidence, documentation and open actions support the next program decision.
Addressing a Program at Risk
Schedule variance, recurring deviations or unresolved technical issues call for a structured review of impact, contributing factors, ownership and recovery actions.
From Partner Decision to Program Oversight
A structured, transparent four-step methodology ensuring seamless alignment from initial scoping through ongoing technical oversight.
ASSESS
Program fit, technical requirements, risks
SELECT
Due diligence & partner comparison
GOVERN
Technical visibility across partners & milestones
INTERVENE
Risk escalation & recovery support
Why Aventiq Bio
Built specifically to eliminate the execution divide between global sponsors and outsourcing providers.
Vendor-Neutral
No labs, no commissions. Recommendations driven only by program fit, technical capability and execution requirements — not laboratory utilization or preferred-provider agendas.
Scientific Depth
Governance grounded in real development experience spanning drug discovery, preclinical, CMC, GMP manufacturing and outsourced development. We understand the science behind the milestones.
On the Ground
India-based technical presence combined with experience supporting international development programs. Closer to your partners. Connected to your program.
Where Technical Governance Makes a Difference
Selected examples of partner assessment, scientific oversight and program governance across outsourced life-sciences development.
Global CRO/CDMO Search & Vendor Qualification
Conducted technical diligence and capability benchmarking across 12 candidate CROs, identifying optimal teams and preventing a 6-month delay.
Strategic CRO Partner Selection for Cardiac Ion Channel Program
Managed partner selection and assay alignment for complex electrophysiology screening, establishing standardized cascades to eliminate data drift.
Integrated CDMO Strategy for an ADC Development Programme
Technical governance bridging high-potency payload synthesis with antibody bioconjugation across facilities, ensuring tight DAR distribution.
Lower risk. Faster execution. Defensible decisions.
100% Vendor-Neutral (No Labs, No Commissions)
.svg)
On-Ground India Presence
Advanced Modality Expertise
Western Regulatory Alignment
Lifecycle Accountability
Featured Case Studies
Explore real-world examples of how our vendor-neutral technical governance, partner diligence, and active oversight de-risk complex development programs.
Built by Someone Who Has Sat on Both Sides of the Outsourcing Table
Ramakrishna Dasoju
Ramakrishna Dasoju brings 20+ years of experience across CRO/CDMO operations, drug discovery, preclinical development, CMC, GMP and global business development.
His experience spans life-sciences organizations and development programs across India and international markets, with a focus on connecting global sponsors with India's scientific, development and manufacturing ecosystem.
“Global sponsors should be able to access India's scientific capabilities without sacrificing technical visibility, accountability or execution confidence.”
Planning to Outsource Development or Manufacturing to India?
Before selecting a CRO or CDMO, know what to evaluate beyond the capability presentation.
Testimonials
Have a Development Program in India?
Let's discuss where vendor-neutral technical governance could reduce risk, improve visibility and strengthen execution across your CRO/CDMO ecosystem.